Jit
Enthusiast computational biologist with business dream !!!
Tag cloud
Bioinformatics, Computational Biology, BLAST, Genomics, R, BINC, NCBI, India, Genome, Protein, sequencing, Exam, Release, FTP, site, RNA-seq, Bioconductor, Features, Tool, BINC2016, Crispr, National, Certification, DBT, ngs, version, database, available, Released, Genomes, GO, Gene Enrichments, Clustering, GO annotation, CRAN, Endocrinology, Sridhar, Vaccination, H1N1, Sorghum, Nature, Crop, Drugs, HIV, Vaccine, SIV, Programming, Synthetic DNA, Nanotechnology, Washington University
Our Sponsors
598 Indian Genomes from 55 ethnic groups Sequenced
By Jit 1804 days ago
- This study reports sequence from 1,267 individuals that includes 598 individuals representing 55 ethnic groups that span the major language groups across India.
- Importantly, this study found many large population groups from India in which individuals were more related to each other by descent. These groups are similar to the Finnish population group where many disease gene discoveries were made. The Finnish-equivalent Indian groups are going to be a great resource for disease gene discovery and they will aid in target identification, drug development and disease management.
- This study has identified many genetic variants that are specific to Indian population groups that were previously not known. Some of these are common variants in the Indian groups, but when first identified by previous studies from India involving smaller sample size, they were thought to be disease causing (for example in diabetes) as they were not represented in the Eurocentric variant database.
- Several variants that pre-dispose individuals to higher cancer risk were identified in this study. Once this part of the work is expanded, the data from this can be used to screen individuals to understand the disease risk and provide appropriate monitoring and proactive treatment. Similarly, variants linked to increase in adverse effect in individuals for certain drugs were found. Understanding this will allow doctors to provide alternate safer drugs to such patients.
